CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Menopause - Management
When should I switch to a continuous combined preparation?
- Consider switching from cyclical therapy to continuous combined therapy when the woman is considered to be postmenopausal. However, it may be difficult to decide when the woman is postmenopausal.
- Women are generally considered to be postmenopausal if:
- They are more than 54 years of age (it is estimated that 80% of women will be postmenopausal by this age).
- They have had previous amenorrhoea or increased levels of follicle-stimulating hormone. Women who experienced 6 months of amenorrhoea or had increased follicle-stimulating hormone levels in their mid-40s are likely to be postmenopausal after taking several years of cyclical hormone replacement therapy.
Basis for recommendation
© NHS Institute for Innovation and Improvement